News
STAT+: Lilly wins approval for once-weekly insulin shot
The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an alternative to daily long-acting insulin injections.
More in Health
- Meal deliveries can save money and improve health. Will they survive Medicaid cuts? NPR — Health
- Drones could speed up getting defibrillators to people having cardiac arrests, study suggests The Guardian — Society
- U.S. Rejects U.N. Declaration on Preparing for Future Pandemics The New York Times — Health
- Trump administration uses rare authority to claw back nearly $1B in spending approved by Congress STAT
- NHS to suspend staff suspected of snooping on patient records BBC News — Health